Get the Stockscreener App
7.49
0.13%
-0.010
Overview
News
Price History
Option Chain
Financials
Why BHC Down?
Discussions
Forecast
Stock Split
Dividend History
Bausch Health Companies Inc stock is traded at $7.49, with a volume of 1.87M.
It is down -0.13% in the last 24 hours and up +15.05% over the past month.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
See More
Previous Close:
$7.50
Open:
$7.54
24h Volume:
1.87M
Relative Volume:
0.86
Market Cap:
$2.77B
Revenue:
$9.47B
Net Income/Loss:
$-178.00M
P/E Ratio:
-15.60
EPS:
-0.48
Net Cash Flow:
$1.01B
1W Performance:
-10.19%
1M Performance:
+15.05%
6M Performance:
+2.46%
1Y Performance:
+29.81%
1-Day Range:
$7.45
$7.72
1-Week Range:
$7.445
$8.4376
52-Week Range:
$4.25
$9.85
Bausch Health Companies Inc Stock (BHC) Company Profile
Name
Bausch Health Companies Inc
Sector
Phone
514-744-6792
Address
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Compare BHC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
7.49 | 2.97B | 9.47B | -178.00M | 1.01B | -0.48 |
|
ZTS
Zoetis Inc
|
156.62 | 67.51B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.52 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.82 | 43.42B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.46 | 20.72B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
312.23 | 14.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-02-24 | Downgrade | Piper Sandler | Neutral → Underweight |
| Jul-10-24 | Initiated | Raymond James | Mkt Perform |
| Sep-20-23 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Jul-29-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jul-29-22 | Downgrade | Truist | Buy → Hold |
| Jul-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-13-22 | Resumed | JP Morgan | Overweight |
| Mar-24-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-17-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-22-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-17-20 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-24-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-17-20 | Reiterated | H.C. Wainwright | Buy |
| Apr-24-20 | Initiated | Citigroup | Buy |
| Apr-02-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-29-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jan-22-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Dec-12-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-02-19 | Initiated | Goldman | Neutral |
| Oct-25-19 | Initiated | Cowen | Outperform |
| Sep-12-19 | Initiated | Guggenheim | Buy |
| Aug-15-19 | Upgrade | TD Securities | Hold → Buy |
| Jul-19-19 | Initiated | Wolfe Research | Outperform |
| Jun-11-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | JP Morgan | Underweight → Neutral |
| Mar-20-19 | Initiated | SunTrust | Buy |
| Jan-02-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Nov-05-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-13-18 | Upgrade | Piper Jaffray | Underweight → Neutral |
View All
Bausch Health Companies Inc Stock (BHC) Latest News
Layoff Tracker: Opthea Slashes 80% of Workforce, 50% of Board - BioSpace
Bausch Health to redeem ~$602M of outstanding notes due 2026 - MSN
Bausch Health (BHC) Climbs 45% on Insider Buying - MSN
Myositis Pipeline 2025: FDA Approvals, Therapies, Clinical Trials, and Latest Developments Unveiled by DelveInsight | Roche, Pfizer, Zydus Group, Lupin, Bausch Health, Accord Healthcare, Genentech - Barchart.com
Bausch Health to acquire liver drug developer Durect for $1.75 per share - MSN
Paulson increases ownership of Bausch Health common shares - MSN
Bausch Health Pick of the Week at Smart Insider Following Non-Executive Chair Paulson's Stock Purchase - MarketScreener
Bausch Health rises after $300M worth insider purchase (update) - MSN
Bausch Health (BHC) Rebounds 15.8% on Bargain-Hunting - MSN
Icahn representations resign Bausch + Lomb board after agreement termination - Reuters
Icahn representatives resign from Bausch + Lomb board as agreement ends By Investing.com - Investing.com Nigeria
Bausch + Lomb board members resign after Icahn agreement ends - Reuters
Strategic Governance Shifts and Shareholder Value at Bausch + Lomb and Bausch Health: A New Era of Stability and Confidence - AInvest
Icahn representatives resign from Bausch + Lomb board as agreement ends - Investing.com
Bausch + Lomb Announces Board Changes - The Globe and Mail
Major Board Shake-up: Icahn Representatives Exit Bausch + Lomb Board as Ownership Falls Below Threshold - Stock Titan
Icahn Group Exits Bausch Boards As Paulson Steps In - Finimize
Does Paulson’s Larger Stake in Bausch Health (BHC) Signal a Shift in Strategic Priorities? - simplywall.st
Bausch Health rises after $300M worth insider purchase - MSN
What makes Bausch Health Companies Inc. stock price move sharply2025 Market Sentiment & Weekly Setup with ROI Potential - sundaytimes.kr
Bausch Health Companies Inc. (NYSE:BHC) Stock Catapults 30% Though Its Price And Business Still Lag The Industry - 富途牛牛
Improved Revenues Required Before Bausch Health Companies Inc. (NYSE:BHC) Stock's 30% Jump Looks Justified - simplywall.st
Options Data Show Bullish Bias in Bausch Health Companies Inc.Trade Risk Report & Weekly Stock Performance Updates - sundaytimes.kr
Visualizing Bausch Health Companies Inc. stock with heatmapsMarket Performance Recap & Long-Term Safe Return Strategies - Newser
Trend analysis for Bausch Health Companies Inc. this weekProduct Launch & Daily Profit Maximizing Tips - Newser
Bausch Health Cos (NYSE:BHC) Shares Gap Up on Insider Buying Activity - Defense World
Bausch Health's Shareholder Shift: Strategic Implications for Governance and Shareholder Value - AInvest
Bausch Health Announces Increase in Shareholding by Its Chairperson of the Board and Board Changes - 富途牛牛
Bausch Health Stake Rises for Paulson Capital; Brett Icahn and Steven Miller Resign as Board Directors - MarketScreener
Bausch Health stock soars after Paulson increases stake By Investing.com - Investing.com Australia
Bausch Health stock soars after Paulson increases stake - Investing.com
Bausch Health stock rises on insider purchase (BHC:NYSE) - Seeking Alpha
BHC Stock Price and Chart — TSX:BHC - TradingView
Bausch Health Brief: Brett M. Icahn and Steven D. Miller Have Resigned from the Board of Directors - MarketScreener
Bausch Health Brief: Announcing that Paulson Capital and Certain Affiliates and Managed Funds Have Increased Their Ownership of Company's Common Shares - MarketScreener
Bausch Health Brief: Announcing Increase in Shareholding by its Chairperson of the Board and Board Changes - MarketScreener
Paulson Capital increases stake in Bausch Health to 19.13% By Investing.com - Investing.com Nigeria
Bausch Health's Shareholder and Board Shake-Up: A Strategic Inflection Point for Value Creation? - AInvest
Paulson Capital increases stake in Bausch Health to 19.13% - Investing.com
Bausch Health Announces Increase in Shareholding by its Chairperson of the Board and Board Changes - ACCESS Newswire
19.13% Ownership Stake: Bausch Health Chairman Paulson Acquires Icahn's Entire Position in Major Shakeup - Stock Titan
Bausch Health’s Strong Q2 Results: What’s Next? - StocksToTrade
Bausch Health Companies shares rise 3.93% intraday after acquiring DURECT Corporation for $63 million and director Paulson John's stock purchase. - AInvest
Bausch Health's Insider Purchase: A Strategic Indicator for Value Investors - AInvest
What is Bausch Health Companies Inc.’s TAM (Total Addressable Market)Inflation Watch & High Accuracy Trade Alerts - sundaytimes.kr
Toronto stocks subdued as investors await pivotal US-Russia meet - MarketScreener
Bausch Health Companies Stock (BHC) Opinions on Insider Buying and Acquisition News - Quiver Quantitative
Paulson John buys $312 million in Bausch Health (BHC) shares By Investing.com - Investing.com Australia
Bausch Health Companies Inc Stock (BHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.37%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):